bitBiome
Unraveling the mysteries of disease-linked microorganisms with single-cell whole-genome analysis.
Unraveling the mysteries of disease-linked microorganisms with single-cell whole-genome analysis.
bitBiome is a microbiome analysis company founded in 2018, with a focus on unraveling disease-linked microorganisms through single-cell whole-genome analysis. The company's slogan, "Unraveling the mysteries of disease-linked microorganisms with single-cell whole-genome analysis," succinctly captures its mission.
bitBiome's approach revolves around identifying and understanding microorganisms associated with diseases by targeting them in their natural, unaltered state. This unique strategy allows for detailed, strain-level quantitative and functional insights that were previously unattainable.
As of 02 November 2020, bitBiome secured a significant ¥30.00M Series B investment from the Japan Science and Technology Agency, indicating both financial backing and recognition within the industry. The company operates in the Analytics and Biotechnology sectors and is headquartered in Japan.
With its pioneering approach and recent investment, bitBiome is poised to make substantial strides in advancing our understanding of disease-linked microorganisms, potentially leading to innovative solutions in the biotechnology and healthcare sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | ¥30.00M | 1 | Japan Science and Technology Agency | 02 Nov 2020 |
| Series B | ¥700.00M | 4 |
|
02 Sep 2020 |
| Seed Round | ¥350.00M | 1 |
|
09 Jan 2019 |
No recent news or press coverage available for bitBiome.
We care about your data, and we'd love to use cookies make your experience better.
